Publications in collaboration with researchers from Hospital General de Castellón (15)

2022

  1. Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients

    RMD Open, Vol. 8, Núm. 2

2017

  1. Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study

    HIV Medicine, Vol. 18, Núm. 7, pp. 482-489

2016

  1. Cut-offs and response criteria for the Hospital Universitario la Princesa Index (HUPI) and their comparison to widely-used indices of disease activity in rheumatoid arthritis

    PLoS ONE, Vol. 11, Núm. 9

2015

  1. Improved prediction of knee osteoarthritis progression by genetic polymorphisms: The Arthrotest Study

    Rheumatology (United Kingdom), Vol. 54, Núm. 7, pp. 1236-1243

  2. Patterns of use and dosing of tocilizumab in the treatment of patients with rheumatoid arthritis in routine clinical practice: the ACT-LIFE study

    Rheumatology International, Vol. 35, Núm. 9, pp. 1525-1534

  3. Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain

    Seminars in Arthritis and Rheumatism, Vol. 44, Núm. 6, pp. 633-640

2013

  1. Development and validation of a new disease activity index as a numerical sum of four variables in patients with early arthritis

    Arthritis Care and Research, Vol. 65, Núm. 4, pp. 518-525

2008

  1. Burden of disease across chronic diseases: A health survey that measured prevalence, function, and quality of life

    Journal of Rheumatology, Vol. 35, Núm. 1, pp. 159-165

  2. Prevalence, risk factors, and impact of knee pain suggesting osteoarthritis in Spain

    Clinical and Experimental Rheumatology, Vol. 26, Núm. 2, pp. 324-332

  3. Reacciones adversas relacionadas con la administración de inhibidores del TNF. Análisis de un registro de terapias biológicas

    Reumatologia Clinica, Vol. 4, Núm. 3, pp. 90-95

2007

  1. Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas (BIOBADASER): Informe de la situación, 26 de enero de 2006

    Reumatologia Clinica, Vol. 3, Núm. 1, pp. 4-20

2006

  1. Switching TNF antagonists in patients with chronic arthritis: An observational study of 488 patients over a four-year period

    Arthritis Research and Therapy, Vol. 8, Núm. 1

2004

  1. Prevelance and associated factors of anterior atlantoaxial luxation in a nation-wide sample of rheumatoid arthritis patients

    Clinical and Experimental Rheumatology, Vol. 22, Núm. 4, pp. 427-432

  2. Value of Disease Activity Score 28 (DAS28) and DAS28-3 Compared to American College of Rheumatology-Defined Remission in Rheumatoid Arthritis

    Journal of Rheumatology, Vol. 31, Núm. 1, pp. 40-46

2003

  1. Patterns of disease modifing antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis

    Journal of Rheumatology, Vol. 30, Núm. 4, pp. 697-704